High depression and anxiety in people with Alzheimer's disease living in retirement homes during the covid-19 crisis

Mohamad El Haj, Emin Altintas, Guillaume Chapelet, Dimitrios Kapogiannis, Karim Gallouj, Mohamad El Haj, Emin Altintas, Guillaume Chapelet, Dimitrios Kapogiannis, Karim Gallouj

Abstract

To cope with Covid-19 and limits its spread among residents, retirement homes have prohibited physical contact between residents and families and friend and, in some cases, even between residents or between residents and caregivers. We investigated the effects of measures against Covid-19 on the mental health of participants with Alzheimer's disease (AD) who live in retirement homes in France. We instructed on-site caregivers to assess depression and anxiety in participants with mild AD who live in retirement homes. Fifty-eight participants consented to participate in the study. The participants rated their depression and anxiety during and before the Covid-19 crisis. Participants reported higher depression (p = .005) and anxiety (p = .004) during than before the Covid-19 crisis. These increases can be attributed to the isolation of the residents and/or to the drastic changes in their daily life and care they receive. While, in their effort to prevent infections, retirement homes are forced to physically separate residents from the outside world and to drastically reduce residents' activities, these decisions are likely to come at a cost to residents with AD and their mental health.

Keywords: Alzheimer's disease; Anxiety; Coronavirus; Covid-19; Depression; Mental health.

Copyright © 2020 Elsevier B.V. All rights reserved.

Figures

Fig. 1
Fig. 1
Depression and anxiety scores (maximum score = 21 points) before and during the Covid-19 crisis. Error bars represent intervals of 95% within-subjects confidence.

References

    1. Ballard C., Bannister C., Solis M., Oyebode F., Wilcock G. The prevalence, associations and symptoms of depression amongst dementia sufferers. J Affect. Disord. 1996;36(3–4):135–144. doi: 10.1016/0165-0327(95)00072-0.
    1. Ballard C., Holmes C., McKeith I., Neill D., O'Brien J., Cairns N., Perry R. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am. J. Psychiatry. 1999;156(7):1039–1045. doi: 10.1176/ajp.156.7.1039.
    1. Burke A.D., Goldfarb D., Bollam P., Khokher S. Diagnosing and treating depression in patients with Alzheimer's disease. Neurol. Ther. 2019;8(2):325–350. doi: 10.1007/s40120-019-00148-5.
    1. Chi S., Yu J.T., Tan M.S., Tan L. Depression in Alzheimer's disease: epidemiology, mechanisms, and management. J. Alzheimers Dis. 2014;42(3):739–755. doi: 10.3233/JAD-140324.
    1. Cohen J. Erlbaum Associates; Hillsdale, NJ: 1988. Statistical Power Analysis For the Behavioral Sciences.
    1. Haj El, M. Antoine, P. Amouyel, P. Lambert, C. J., Pasquier F., Kapogiannis D. Apolipoprotein E (APOE) epsilon4 and episodic memory decline in Alzheimer's disease: a review. Age. Res. Rev. 2016;27:15–22. doi: 10.1016/j.arr.2016.02.002.
    1. Ellis P.D. Cambridge University Press; New York, NY: 2010. The Essential Guide to Effect Sizes: Statistical Power, Meta-Analysis, and the Interpretation of Research Results.
    1. Enache D., Winblad B., Aarsland D. Depression in dementia: epidemiology, mechanisms, and treatment. Curr. Opin. Psychiatry. 2011;24(6):461–472. doi: 10.1097/YCO.0b013e32834bb9d4.
    1. Ferretti L., McCurry S.M., Logsdon R., Gibbons L., Teri L. Anxiety and Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 2001;14(1):52–58. doi: 10.1177/089198870101400111.
    1. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 1975;12(3):189–198.
    1. Gaugler J.E., Yu F., Krichbaum K., Wyman J.F. Predictors of nursing home admission for persons with dementia. Med. Care. 2009;47(2):191–198. doi: 10.1097/MLR.0b013e31818457ce.
    1. Gimson A., Schlosser M., Huntley J.D., Marchant N.L. Support for midlife anxiety diagnosis as an independent risk factor for dementia: a systematic review. BMJ Open. 2018;8(4) doi: 10.1136/bmjopen-2017-019399.
    1. Gormley N., Rizwan M.R. Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease. Int. J. Geriatr. Psychiatry. 1998;13(6):410–414.
    1. Herrmann C. International experiences with the hospital anxiety and depression scale–a review of validation data and clinical results. J. Psychosom. Res. 1997;42(1):17–41.
    1. Ismail Z., Smith E.E., Geda Y., Sultzer D., Brodaty H., Smith G., Area I.N.S.P.I. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12(2):195–202. doi: 10.1016/j.jalz.2015.05.017.
    1. Kaufer D.I., Cummings J.L., Christine D., Bray T., Castellon S., Masterman D., DeKosky S.T. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the neuropsychiatric inventory caregiver distress scale. J. Am. Geriatr. Soc. 1998;46(2):210–215. doi: 10.1111/j.1532-5415.1998.tb02542.x.
    1. Krishnan K.R., Tupler L.A., Ritchie J.C., Jr., McDonald W.M., Knight D.L., Nemeroff C.B., Carroll B.J. Apolipoprotein E-epsilon 4 frequency in geriatric depression. Biol. Psychiatry. 1996;40(1):69–71. doi: 10.1016/0006-3223(95)00424-6.
    1. Lyketsos C.G., Olin J. Depression in Alzheimer's disease: overview and treatment. Biol. Psychiatry. 2002;52(3):243–252.
    1. Mah L., Binns M.A., Steffens D.C., Alzheimer's Disease Neuroimaging, I. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. Am. J. Geriatr. Psychiatry. 2015;23(5):466–476. doi: 10.1016/j.jagp.2014.10.005.
    1. McKhann G., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Jr., Kawas C.H., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263–269. doi: 10.1016/j.jalz.2011.03.005.
    1. Mintzer J.E., Brawman-Mintzer O., Mirski D.F., Barkin K. Anxiety in the behavioral and psychological symptoms of dementia. Int. Psychogeriatr. 2005;12(S1):139–142. doi: 10.1017/S104161020000692X.
    1. Pietrzak R.H., Lim Y.Y., Neumeister A., Ames D., Ellis K.A., Harrington K., Lifestyle Research, G. Amyloid-beta, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. JAMA Psychiatry. 2015;72(3):284–291. doi: 10.1001/jamapsychiatry.2014.2476.
    1. Qiu W.Q., Zhu H., Dean M., Liu Z., Vu L., Fan G., Au R. Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease. Int. J. Geriatr. Psychiatry. 2016;31(3):316–322. doi: 10.1002/gps.4339.
    1. Rapp M.A., Schnaider-Beeri M., Grossman H.T., Sano M., Perl D.P., Purohit D.P., Haroutunian V. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch. Gen. Psychiatry. 2006;63(2):161–167. doi: 10.1001/archpsyc.63.2.161.
    1. Rosenthal R., DiMatteo M.R. Meta-analysis: recent developments in quantitative methods for literature reviews. Ann. Rev. Psychol., 52. 2001:59–82. doi: 10.1146/annurev.psych.52.1.59.
    1. Salim S., Chugh G., Asghar M. Chapter one - inflammation in anxiety. In: Donev R., editor. Vol. 88. Academic Press; 2012. pp. 1–25. (Advances in Protein Chemistry and Structural Biology).
    1. Santabarbara J., Villagrasa B., Lopez-Anton R., Olaya B., Bueno-Notivol J., de la Camara C., Lobo A. Clinically relevant anxiety and risk of Alzheimer's disease in an elderly community sample: 4.5 years of follow-up. J. Affect. Disord. 2019;250:16–20. doi: 10.1016/j.jad.2019.02.050.
    1. Starkstein S.E., Jorge R., Mizrahi R., Robinson R.G. The construct of minor and major depression in Alzheimer's disease. Am. J. Psychiatry. 2005;162(11):2086–2093. doi: 10.1176/appi.ajp.162.11.2086.
    1. Suh G.H., Kil Yeon B., Shah A., Lee J.Y. Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homes. Int. J. Geriatr. Psychiatry. 2005;20(1):26–34. doi: 10.1002/gps.1256.
    1. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatry Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner